Evaluation of the relationship between fall risk, muscle strength, and anticholinergic burden in geriatric patients presenting to the emergency department
NCT ID NCT07813143
First seen Sep 10, 2026 · Last updated Sep 10, 2026
Summary
Falls are common among older adults and can lead to serious injury. This study looks at whether taking many medications (polypharmacy), the anticholinergic burden of those medications (a measure of side effects that can affect memory, balance, and muscle function), and sarcopenia (age-related loss of muscle mass and strength) are related to fall risk in older adults visiting the emergency department. Patients aged 65 and older who come to the emergency department will be invited to take part. With their consent, researchers will review the medications they are taking and calculate an anticholinergic burden score. Researchers will also measure the patients' hand grip strength and use ultrasound to measure the thickness of the quadriceps muscle in the thigh, both of which are used to assess muscle health. Information about the patients' history of falls in the past year, hospital stays, and other health conditions will also be collected. All measurements are non-invasive, are already used in routine clinical practice, and are performed only once during the emergency department visit. No experimental treatment or medication will be given as part of this study. The goal of this study is to understand how polypharmacy, anticholinergic burden, and sarcopenia relate to fall risk, both individually and together, so that older adults at higher risk of falling can be identified earlier and offered appropriate prevention strategies.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 333 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients aged 65 years and older presenting to the Emergency Department of Gazi University Hospital, enrolled consecutively based on eligibility criteria.
- Ages
-
65 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age 65 years or older * Presenting to the emergency department * Willing and able to provide written informed consent Exclusion Criteria: * Prior major upper or lower extremity surgery, prosthesis, or amputation preventing ultrasound or hand-grip strength measurement * Acute bilateral femur or hip fracture precluding measurement * Neuromuscular disease (e.g., ALS, myopathy) * Terminal or palliative status with limited ability to cooperate with measurements * Severe delirium or inability to cooperate with hand-grip testing * ECOG Performance Status of 3 or 4 * Bedbound status and/or stroke sequelae preventing assessment * Patients who decline to participate
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anticholinergics are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Gazi University
Ankara, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Relationship between gastrocnemius and soleus muscle thickness assessed by ultrasound and balance and fear of falling in hemiplegic patients
- A multi-center, randomized, double-blind, placebo-controlled, phase 1/2 clinical trial to evaluate the efficacy and safety of EN001 in patients with sarcopenia
- Skeletal muscle myosin binding protein c in fatigue and aging
- ACTIVE: adding life to years in cognitive frailty by preventing falls
- Can exercise counteract Cancer's muscle wasting?
- Hidden muscle loss in Sjögren's syndrome: a new study looks for answers